Identification of beta-2 as a key cell adhesion molecule in PCa cell neurotropic behavior: A novel ex vivo and biophysical approach

PLoS ONE

Volumn 9, Issue 6, 2014, Pages

  Jansson, Keith H ^a   Castillo, Deborah G ^b   Morris, Joseph W ^a   Boggs, Mary E ^a   Czymmek, Kirk J ^a   Adams, Elizabeth L ^a   Schramm, Lawrence P ^b   Sikes, Robert A ^a  

^a UNIVERSITY OF DELAWARE   (United States)

^b Johns Hopkins University   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL ADHESION MOLECULE; HYBRID PROTEIN; LAMININ; MEMBRANE PROTEIN; MESSENGER RNA; NEUROTROPIC AGENT; SODIUM CHANNEL; BACTERIAL PROTEIN; PHOTOPROTEIN; PROTEIN BINDING; RECOMBINANT PROTEIN; VOLTAGE GATED SODIUM CHANNEL BETA 2 SUBUNIT; YELLOW FLUORESCENT PROTEIN, BACTERIA;

ANIMAL EXPERIMENT; ARTICLE; ATOMIC FORCE MICROSCOPY; BINDING AFFINITY; CANCER CELL; CASTRATION RESISTANT PROSTATE CANCER; CELL GROWTH; CELL INVASION; CELL MIGRATION; CELL STRUCTURE; CHINESE HAMSTER; COCULTURE; CONTROLLED STUDY; ENDONEURIUM; EX VIVO STUDY; GENE INTERACTION; IN VITRO STUDY; LNCAP CELL LINE; METASTASIS; NONHUMAN; NUCLEOTIDE SEQUENCE; PROSTATE CANCER; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN EXPRESSION; SPINAL CORD; AMINO ACID SEQUENCE; ANIMAL; BIOPHYSICS; CELL ADHESION; CELL MOTION; CELL PROLIFERATION; CELL SURVIVAL; CHEMISTRY; DRUG EFFECTS; HUMAN; MALE; METABOLISM; MOLECULAR GENETICS; NERVE CELL; NERVE FIBER; PATHOLOGY; PROSTATE TUMOR; PROTEIN MOTIF; PROTEIN TERTIARY STRUCTURE; TRANSGENIC MOUSE; TUMOR CELL LINE; TUMOR INVASION; YOUNG MODULUS;

AMINO ACID MOTIFS; AMINO ACID SEQUENCE; ANIMALS; AXONS; BACTERIAL PROTEINS; BIOPHYSICAL PHENOMENA; CELL ADHESION; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; CELL SURVIVAL; ELASTIC MODULUS; HUMANS; LAMININ; LUMINESCENT PROTEINS; MALE; MICE, TRANSGENIC; MICROSCOPY, ATOMIC FORCE; MOLECULAR SEQUENCE DATA; NEOPLASM INVASIVENESS; NEURONS; PROSTATIC NEOPLASMS; PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY; RECOMBINANT PROTEINS; SPINAL CORD; VOLTAGE-GATED SODIUM CHANNEL BETA-2 SUBUNIT;

EID: 84902438798     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0098408     Document Type: Article

References (85)

1. Siegel R, Ma J, Zou Z, Jemal A (2014) Cancer statistics, 2014. CA Cancer J Clin 64: 9-29.
2. Walsh PC, Worthington JF (2002) Dr. Patrick Walsh's guide to surviving prostate cancer. New York: Warner Books. xvi, 462 p. p.
3. Carlin BI, Andriole GL (2000) The natural history, skeletal complications, and management of bone metastases in patients with prostate carcinoma. Cancer 88: 2989-2994.
4. Hellerstedt BA, Pienta KJ (2002) The current state of hormonal therapy for prostate cancer. CA Cancer J Clin 52: 154-179.
5. Mundy GR, Rubens RD (2000) Cancer and the Skeleton. Malden, MA: Blackwell Science.
6. Edlund M, Miyamoto T, Sikes RA, Ogle R, Laurie GW, et al. (2001) Integrin expression and usage by prostate cancer cell lines on laminin substrata. Cell Growth Differ 12: 99-107.
7. Koeneman KS, Yeung F, Chung LW (1999) Osteomimetic properties of prostate cancer cells: a hypothesis supporting the predilection of prostate cancer metastasis and growth in the bone environment. Prostate 39: 246-261.
8. Loberg RD, Gayed BA, Olson KB, Pienta KJ (2005) A paradigm for the treatment of prostate cancer bone metastases based on an understanding of tumor cell-microenvironment interactions. J Cell Biochem 96: 439-446.
9. Kamiya N, Suzuki H, Endo T, Yano M, Naoi M, et al. (2012) Clinical usefulness of bone markers in prostate cancer with bone metastasis. Int J Urol 19: 968-979.
10. Batson OV (1967) The vertebral system of veins as a means for cancer dissemination. Prog Clin Cancer 3: 1-18.
11. Batson OV (1995) The function of the vertebral veins and their role in the spread of metastases. 1940. Clin Orthop: 4-9.
12. McVary KT, Razzaq A, Lee C, Venegas MF, Rademaker A, et al. (1994) Growth of the rat prostate gland is facilitated by the autonomic nervous system. Biol Reprod 51: 99-107.
13. McVary KT, McKenna KE, Lee C (1998) Prostate innervation. Prostate Suppl 8: 2-13.
14. Powell MS, Li R, Dai H, Sayeeduddin M, Wheeler TM, et al. (2005) Neuroanatomy of the normal prostate. Prostate 65: 52-57.
15. Liebig C, Ayala G, Wilks JA, Berger DH, Albo D (2009) Perineural invasion in cancer: a review of the literature. Cancer 115: 3379-3391.
16. Hebert-Blouin MN, Amrami KK, Loukas M, Spinner RJ (2010) A proposed anatomical explanation for perineural spread of breast adenocarcinoma to the brachial plexus. Clin Anat 25: 101-105.
17. Panizza B, Warren T (2013) Perineural Invasion of Head and Neck Skin Cancer: Diagnostic and Therapeutic Implications. Curr Oncol Rep 15: 128-133.
18. Ma J, Jiang Y, Sun Y, Zhao X (2008) Expression of nerve growth factor and tyrosine kinase receptor A and correlation with perineural invasion in pancreatic cancer. J Gastroenterol Hepatol 23: 1852-1859.
19. Liebig C, Ayala G, Wilks J, Verstovsek G, Liu H, et al. (2009) Perineural invasion is an independent predictor of outcome in colorectal cancer. J Clin Oncol 27: 5131-5137.
20. Velazquez EF, Ayala G, Liu H, Chaux A, Zanotti M, et al. (2008) Histologic grade and perineural invasion are more important than tumor thickness as predictor of nodal metastasis in penile squamous cell carcinoma invading 5 to 10 mm. Am J Surg Pathol 32: 974-979.
21. Ayala GE, Dai H, Powell M, Li R, Ding Y, et al. (2008) Cancer-related axonogenesis and neurogenesis in prostate cancer. Clin Cancer Res 14: 7593-7603.
22. Ayala GE, Dai H, Ittmann M, Li R, Powell M, et al. (2004) Growth and survival mechanisms associated with perineural invasion in prostate cancer. Cancer Res 64: 6082-6090.
23. Ayala GE, Dai H, Li R, Ittmann M, Thompson TC, et al. (2006) Bystin in perineural invasion of prostate cancer. Prostate 66: 266-272.
24. Ayala GE, Dai H, Tahir SA, Li R, Timme T, et al. (2006) Stromal antiapoptotic paracrine loop in perineural invasion of prostatic carcinoma. Cancer Res 66: 5159-5164.
25. Ayala GE, Wheeler TM, Shine HD, Schmelz M, Frolov A, et al. (2001) In vitro dorsal root ganglia and human prostate cell line interaction: redefining perineural invasion in prostate cancer. Prostate 49: 213-223.
26. Magnon C, Hall SJ, Lin J, Xue X, Gerber L, et al. (2013) Autonomic nerve development contributes to prostate cancer progression. Science 341: 1236361.
27. Marchesi F, Piemonti L, Mantovani A, Allavena P (2010) Molecular mechanisms of perineural invasion, a forgotten pathway of dissemination and metastasis. Cytokine Growth Factor Rev 21: 77-82.
28. Lee JT, Lee S, Yun CJ, Jeon BJ, Kim JM, et al. (2010) Prediction of perineural invasion and its prognostic value in patients with prostate cancer. Korean J Urol 51: 745-751.
29. Epstein JI (1998) The role of perineural invasion and other biopsy characteristics as prognostic markers for localized prostate cancer. Semin Urol Oncol 16: 124-128.
30. Jeon HG, Bae J, Yi JS, Hwang IS, Lee SE, et al. (2009) Perineural invasion is a prognostic factor for biochemical failure after radical prostatectomy. Int J Urol 16: 682-686.
31. Ozcan F (2001) Correlation of perineural invasion on radical prostatectomy specimens with other pathologic prognostic factors and PSA failure. Eur Urol 40: 308-312.
32. Ng JC, Koch MO, Daggy JK, Cheng L (2004) Perineural invasion in radical prostatectomy specimens: lack of prognostic significance. J Urol 172: 2249-2251.
33. Shariat SF, Khoddami SM, Saboorian H, Koeneman KS, Sagalowsky AI, et al. (2004) Lymphovascular invasion is a pathological feature of biologically aggressive disease in patients treated with radical prostatectomy. J Urol 171: 1122-1127.
34. Yu HH, Song DY, Tsai YY, Thompson T, Frassica DA, et al. (2007) Perineural invasion affects biochemical recurrence-free survival in patients with prostate cancer treated with definitive external beam radiotherapy. Urology 70: 111-116.
35. Lee IH, Roberts R, Shah RB, Wojno KJ, Wei JT, et al. (2007) Perineural invasion is a marker for pathologically advanced disease in localized prostate cancer. Int J Radiat Oncol Biol Phys 68: 1059-1064.
36. Masieri L, Lanciotti M, Nesi G, Lanzi F, Tosi N, et al. (2010) Prognostic role of perineural invasion in 239 consecutive patients with pathologically organ-confined prostate cancer. Urol Int 85: 396-400.
37. Villers A, McNeal JE, Redwine EA, Freiha FS, Stamey TA (1989) The role of perineural space invasion in the local spread of prostatic adenocarcinoma. J Urol 142: 763-768.
38. Hebert-Blouin MN, Amrami KK, Myers RP, Hanna AS, Spinner RJ (2010) Adenocarcinoma of the prostate involving the lumbosacral plexus: MRI evidence to support direct perineural spread. Acta Neurochir (Wien) 152: 1567-1576.
39. Ladha SS, Spinner RJ, Suarez GA, Amrami KK, Dyck PJ (2006) Neoplastic lumbosacral radiculoplexopathy in prostate cancer by direct perineural spread: an unusual entity. Muscle Nerve 34: 659-665.
40. Sroka IC, Anderson TA, McDaniel KM, Nagle RB, Gretzer MB, et al. (2010) The laminin binding integrin alpha6beta1 in prostate cancer perineural invasion. J Cell Physiol 224: 283-288.
41. Fiske JL, Fomin VP, Brown ML, Duncan RL, Sikes RA (2006) Voltage-sensitive ion channels and cancer. Cancer Metastasis Rev 25: 493-500.
42. Djamgoz MB, Onkal R (2013) Persistent current blockers of voltage-gated sodium channels: a clinical opportunity for controlling metastatic disease. Recent Pat Anticancer Drug Discov 8: 66-84.
43. Catterall WA (2000) From ionic currents to molecular mechanisms: the structure and function of voltage-gated sodium channels. Neuron: 13-25.
44. Isom LL (2001) Sodium channel beta subunits: anything but auxiliary. Neuroscientist 7: 42-54.
45. Goldin AL, Barchi RL, Caldwell JH, Hofmann F, Howe JR, et al. (2000) Nomenclature of voltage-gated sodium channels. Neuron 28: 365-368.
46. Isom LL, Catterall WA (1996) Na+ channel subunits and Ig domains. Nature 383: 307-308.
47. Catterall WA (1992) Cellular and molecular biology of voltage-gated sodium channels. Physiol Rev 72 (4 Suppl): S15-48.
48. Meadows L, Malhotra JD, Stetzer A, Isom LL, Ragsdale DS (2001) The intracellular segment of the sodium channel beta 1 subunit is required for its efficient association with the channel alpha subunit. J Neurochem 76: 1871-1878.
49. Aman TK, Grieco-Calub TM, Chen C, Rusconi R, Slat EA, et al. (2009) Regulation of persistent Na current by interactions between beta subunits of voltage-gated Na channels. J Neurosci 29: 2027-2042.
50. Grieco TM, Malhotra JD, Chen C, Isom LL, Raman IM (2005) Open-channel block by the cytoplasmic tail of sodium channel beta4 as a mechanism for resurgent sodium current. Neuron 45: 233-244.
51. Yu FH, Westenbroek RE, Silos-Santiago I, McCormick KA, Lawson D, et al. (2003) Sodium channel beta4, a new disulfide-linked auxiliary subunit with similarity to beta2. J Neurosci 23: 7577-7585.
52. Srinivasan J, Schachner M, Catterall WA (1998) Interaction of voltage-gated sodium channels with the extracellular matrix molecules tenascin-C and tenascin-R. Proc Natl Acad Sci U S A 95: 15753-15757.
53. Xiao ZC, Ragsdale DS, Malhotra JD, Mattei LN, Braun PE, et al. (1999) Tenascin-R is a functional modulator of sodium channel beta subunits. J Biol Chem 274: 26511-26517.
54. McEwen DP, Meadows LS, Chen C, Thyagarajan V, Isom LL (2004) Sodium channel beta1 subunit-mediated modulation of Nav1.2 currents and cell surface density is dependent on interactions with contactin and ankyrin. J Biol Chem 279: 16044-16049.
55. Brackenbury WJ, Isom LL (2011) Na Channel beta Subunits: Overachievers of the Ion Channel Family. Front Pharmacol 2: 53.
56. Kazarinova-Noyes K, Malhotra JD, McEwen DP, Mattei LN, Berglund EO, et al. (2001) Contactin associates with Na+ channels and increases their functional expression. J Neurosci 21: 7517-7525.
57. Malhotra JD, Koopmann MC, Kazen-Gillespie KA, Fettman N, Hortsch M, et al. (2002) Structural requirements for interaction of sodium channel beta 1 subunits with ankyrin. J Biol Chem 277: 26681-26688.
58. Malhotra JD, Kazen-Gillespie K, Hortsch M, Isom LL (2000) Sodium channel beta subunits mediate homophilic cell adhesion and recruit ankyrin to points of cell-cell contact. J Biol Chem 275: 11383-11388.
59. Chen C, Calhoun JD, Zhang Y, Lopez-Santiago L, Zhou N, et al. (2012) Identification of the cysteine residue responsible for disulfide linkage of Na+ channel alpha and beta2 subunits. J Biol Chem 287: 39061-39069.
60. Isom LL, Ragsdale DS, De Jongh KS, Westenbroek RE, Reber BF, et al (1995) Structure and function of the beta 2 subunit of brain sodium channels, a transmembrane glycoprotein with a CAM motif. Cell 83(3): 433-442.
61. Diss JK, Fraser SP, Walker MM, Patel A, Latchman DS, et al. (2008) Beta-subunits of voltage-gated sodium channels in human prostate cancer: quantitative in vitro and in vivo analyses of mRNA expression. Prostate Cancer Prostatic Dis 11: 325-333.
62. Jansson KH, Lynch JE, Lepori-Bui N, Czymmek KJ, Duncan RL, et al. (2012) Overexpression of the VSSC-associated CAM, beta-2, enhances LNCaP cell metastasis associated behavior. Prostate 72: 1080-1092.
63. Pierce BG, Hourai Y, Weng Z (2011) Accelerating protein docking in ZDOCK using an advanced 3D convolution library. PLoS One 6: e24657.
64. Guex N, Peitsch MC (1997) SWISS-MODEL and the Swiss-PdbViewer: an environment for comparative protein modeling. Electrophoresis 18: 2714-2723.
65. Horoszewicz JS, Leong SS, Chu TM, Wajsman ZL, Friedman M, et al. (1980) The LNCaP cell line-a new model for studies on human prostatic carcinoma. Prog Clin Biol Res 37: 115-132.
66. Horoszewicz JS, Leong SS, Kawinski E, Karr JP, Rosenthal H, et al. (1983) LNCaP model of human prostatic carcinoma. Cancer Res 43: 1809-1818.
67. Thalmann GN, Anezinis PE, Chang SM, Zhau HE, Kim EE, et al. (1994) Androgen-independent cancer progression and bone metastasis in the LNCaP model of human prostate cancer [published erratum appears in Cancer Res 1994 Jul 15;54(14):3953]. Cancer Research 54: 2577-2581.
68. Thalmann GN, Sikes RA, Wu TT, Degeorges A, Chang SM, et al. (2000) LNCaP progression model of human prostate cancer: androgen-independence and osseous metastasis. Prostate 44: 91-103 Jul 101;144 (102).
69. Kuhn TB, Meberg PJ, Brown MD, Bernstein BW, Minamide LS, et al. (2000) Regulating actin dynamics in neuronal growth cones by ADF/cofilin and rho family GTPases. J Neurobiol 44: 126-144.
70. Feng G, Mellor RH, Bernstein M, Keller-Peck C, Nguyen QT, et al. (2000) Imaging neuronal subsets in transgenic mice expressing multiple spectral variants of GFP. Neuron 28: 41-51.
71. Castillo DG, Valdivia D, Schramm LP (2011) Characterization of the axonguiding cells in organotypic cultures of thoracic spinal slices. Johns Hopkins University, Department of Biomedical Engineering. Society for Neuroscience. Washington, D.C., 2011.
72. Eldridge CF, Bunge MB, Bunge RP, Wood PM (1987) Differentiation of axon-related Schwann cells in vitro. I. Ascorbic acid regulates basal lamina assembly and myelin formation. J Cell Biol 105: 1023-1034.
73. Eldridge CF, Bunge MB, Bunge RP (1989) Differentiation of axon-related Schwann cells in vitro: II. Control of myelin formation by basal lamina. J Neurosci 9: 625-638.
74. Obremski VJ, Bunge MB (1995) Addition of purified basal lamina molecules enables Schwann cell ensheathment of sympathetic neurites in culture. Dev Biol 168: 124-137.
75. Platika D, Boulos MH, Baizer L, Fishman MC (1985) Neuronal traits of clonal cell lines derived by fusion of dorsal root ganglia neurons with neuroblastoma cells. Proc Natl Acad Sci U S A 82: 3499-3503.
76. Sequeira L, Dubyk CW, Riesenberger TA, Cooper CR, van Golen KL (2008) Rho GTPases in PC-3 prostate cancer cell morphology, invasion and tumor cell diapedesis. Clin Exp Metastasis 25: 569-579.
77. Lekka M, Gil D, Pogoda K, Dulinska-Litewka J, Jach R, et al. (2011) Cancer cell detection in tissue sections using AFM. Arch Biochem Biophys 518: 151-156.
78. Lekka M, Pogoda K, Gostek J, Klymenko O, Prauzner-Bechcicki S, et al. (2012) Cancer cell recognition - Mechanical phenotype. Micron 43: 1259-1266.
79. Jin H, Pi J, Huang X, Huang F, Shao W, et al. (2012) BMP2 promotes migration and invasion of breast cancer cells via cytoskeletal reorganization and adhesion decrease: an AFM investigation. Appl Microbiol Biotechnol 93: 1715-1723.
80. Li QS, Lee GY, Ong CN, Lim CT (2008) AFM indentation study of breast cancer cells. Biochem Biophys Res Commun 374: 609-613.
81. Bastatas L, Martinez-Marin D, Matthews J, Hashem J, Lee YJ, et al. (2012) AFM nano-mechanics and calcium dynamics of prostate cancer cells with distinct metastatic potential. Biochim Biophys Acta 1820: 1111-1120.
82. Brown EJ, Frazier WA (2001) Integrin-associated protein (CD47) and its ligands. Trends Cell Biol 11: 130-135.
83. Nagle RB, Knox JD, Wolf C, Bowden GT, Cress AE (1994) Adhesion molecules, extracellular matrix, and proteases in prostate carcinoma. J Cell Biochem Suppl 19: 232-237.
84. Lin M, DiVito MM, Merajver SD, Boyanapalli M, van Golen KL (2005) Regulation of pancreatic cancer cell migration and invasion by RhoC GTPase and caveolin-1. Mol Cancer 4: 21.
85. van Golen KL, Wu ZF, Qiao XT, Bao LW, Merajver SD (2000) RhoC GTPase, a novel transforming oncogene for human mammary epithelial cells that partially recapitulates the inflammatory breast cancer phenotype. Cancer Res 60: 5832-5838.